| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/06/1997 | CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/05/1997 | EP0759757A1 Oral liquid alendronate formulations |
| 03/05/1997 | CN1144217A Retinoid-like compounds |
| 03/05/1997 | CN1144128A Pure traditional Chinese medicinal liquor with antisenile action |
| 03/05/1997 | CN1144119A Medicine for curing hyperosteogeny |
| 03/05/1997 | CN1144100A Medicine for curing bone tuberculosis and osteomyelitis |
| 03/04/1997 | US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/04/1997 | US5607952 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/04/1997 | US5607915 Pulmonary delivery of active fragments of parathyroid hormone |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997006796A1 Benzothiophene compounds |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/26/1997 | EP0759434A1 Benzothiophene compounds |
| 02/26/1997 | EP0759432A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition |
| 02/26/1997 | EP0593418B1 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143505A Preparing process of Chinese drug preparation for curing cervical vertebrae syndrome |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/20/1997 | WO1997006254A1 Human mp52 arg protein |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005863A1 Preventive or remedy for diseases caused by abnormalities in cartilage tissues |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2227204A1 Human mp52 arg protein |
| 02/19/1997 | EP0758252A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | CN1142968A Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny |
| 02/19/1997 | CN1142955A Quick-action bone injury medicine and preparing method |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142772A Parathyroid hormone formulation |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1142395A Medicine "Gu'anshuang" and preparation thereof |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602166 Administering an azaspirane derivatives |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997003668A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 02/06/1997 | CA2224289A1 New protein hmw human mp52s |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756483A1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1141920A Thiophene compound, its preparation method and medicinal composition containing same |
| 02/04/1997 | US5599833 Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997002837A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | WO1997002834A1 Analogs of parathyroid hormone |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002820A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 01/30/1997 | CA2235718A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/29/1997 | CN1141184A Method of preparing medicated wine for treating injury and setting bone |
| 01/29/1997 | CN1141177A Traditional Chinese medicine for curing arthralgia-syndrome |
| 01/28/1997 | US5597897 Polymer matrix made from lactic acid and/or glycolic acid for sequestering proteins |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754190A1 An equilin double bond isomer from the acid isomerization of equilin |
| 01/22/1997 | EP0754173A1 Method for purifying diacetyl rhein |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1140710A N,N-diethyl-8,8-dipropyl-2-azaspiro(4,5) decane-2-propanamine dimaleate |
| 01/22/1997 | CN1140607A Preparing method of Jianyanling-medicine for omitis |
| 01/22/1997 | CN1140593A 骨伤酊 Orthopedics tincture |
| 01/16/1997 | WO1997001570A1 Colchicine derivatives, the use thereof and formulations containing them |
| 01/16/1997 | WO1997001549A1 Benzothiophene compounds |
| 01/16/1997 | WO1997001540A1 Integrin receptor antagonists |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | CA2220991A1 Benzothiophene compounds |
| 01/15/1997 | EP0753512A1 N,N,-diethyl-8,8dipropyl-2-azaspiro(4,5)decane-2-propanamine dimaleate salt |
| 01/15/1997 | EP0753302A1 Osteoporosis preventing or treating agent |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140086A Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593882 Selectin variants |
| 01/09/1997 | WO1997000692A1 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 01/09/1997 | WO1997000675A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | CA2225462A1 Analgesic use of n-l-.alpha.-aspartyl-l-phenylalanine 1-methyl ester |